203 related articles for article (PubMed ID: 20368698)
1. The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice.
Fickert P; Thueringer A; Moustafa T; Silbert D; Gumhold J; Tsybrovskyy O; Lebofsky M; Jaeschke H; Denk H; Trauner M
Lab Invest; 2010 Jun; 90(6):844-52. PubMed ID: 20368698
[TBL] [Abstract][Full Text] [Related]
2. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.
Fickert P; Stöger U; Fuchsbichler A; Moustafa T; Marschall HU; Weiglein AH; Tsybrovskyy O; Jaeschke H; Zatloukal K; Denk H; Trauner M
Am J Pathol; 2007 Aug; 171(2):525-36. PubMed ID: 17600122
[TBL] [Abstract][Full Text] [Related]
3. Effects of Melittin Treatment in Cholangitis and Biliary Fibrosis in a Model of Xenobiotic-Induced Cholestasis in Mice.
Kim KH; Sung HJ; Lee WR; An HJ; Kim JY; Pak SC; Han SM; Park KK
Toxins (Basel); 2015 Aug; 7(9):3372-87. PubMed ID: 26308055
[TBL] [Abstract][Full Text] [Related]
4. Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.
Elßner C; Goeppert B; Longerich T; Scherr AL; Stindt J; Nanduri LK; Rupp C; Kather JN; Schmitt N; Kautz N; Breuhahn K; Ismail L; Heide D; Hetzer J; García-Beccaria M; Hövelmeyer N; Waisman A; Urbanik T; Mueller S; Gdynia G; Banales JM; Roessler S; Schirmacher P; Jäger D; Schölch S; Keitel V; Heikenwalder M; Schulze-Bergkamen H; Köhler BC
Gastroenterology; 2019 Mar; 156(4):1190-1205.e14. PubMed ID: 30445013
[TBL] [Abstract][Full Text] [Related]
5. Selective deletion of ENTPD1/CD39 in macrophages exacerbates biliary fibrosis in a mouse model of sclerosing cholangitis.
Rothweiler S; Feldbrügge L; Jiang ZG; Csizmadia E; Longhi MS; Vaid K; Enjyoji K; Popov YV; Robson SC
Purinergic Signal; 2019 Sep; 15(3):375-385. PubMed ID: 31243614
[TBL] [Abstract][Full Text] [Related]
6. Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction.
Chen Y; Guldiken N; Spurny M; Mohammed HH; Haybaeck J; Pollheimer MJ; Fickert P; Gassler N; Jeon MK; Trautwein C; Strnad P
J Pathol; 2015 Nov; 237(3):343-54. PubMed ID: 26108453
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin is an initial mediator of inflammation and liver injury during obstructive cholestasis after bile duct ligation in mice.
Yang M; Ramachandran A; Yan HM; Woolbright BL; Copple BL; Fickert P; Trauner M; Jaeschke H
Toxicol Lett; 2014 Jan; 224(2):186-95. PubMed ID: 24188933
[TBL] [Abstract][Full Text] [Related]
8. 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine Diet: A Rodent Model in Cholestasis Research.
Pose E; Sancho-Bru P; Coll M
Methods Mol Biol; 2019; 1981():249-257. PubMed ID: 31016659
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin deficiency aggravates hepatic injury induced by ischemia-reperfusion in mice.
Patouraux S; Rousseau D; Rubio A; Bonnafous S; Lavallard VJ; Lauron J; Saint-Paul MC; Bailly-Maitre B; Tran A; Crenesse D; Gual P
Cell Death Dis; 2014 May; 5(5):e1208. PubMed ID: 24810044
[TBL] [Abstract][Full Text] [Related]
10. Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis.
Tardelli M; Bruschi FV; Fuchs CD; Claudel T; Auer N; Kunczer V; Baumgartner M; A H O Ronda O; Verkade HJ; Stojakovic T; Scharnagl H; Habib A; Zimmermann R; Lotersztajn S; Trauner M
Hepatology; 2020 May; 71(5):1750-1765. PubMed ID: 31505038
[TBL] [Abstract][Full Text] [Related]
11. Geniposide suppresses liver injury in a mouse model of DDC-induced sclerosing cholangitis.
Wen M; Liu Y; Chen R; He P; Wu F; Li R; Lin Y
Phytother Res; 2021 Jul; 35(7):3799-3811. PubMed ID: 33763888
[TBL] [Abstract][Full Text] [Related]
12. Impaired bile acid handling and aggravated liver injury in mice expressing a hepatocyte-specific RXRα variant lacking the DNA-binding domain.
Kosters A; Felix JC; Desai MS; Karpen SJ
J Hepatol; 2014 Feb; 60(2):362-9. PubMed ID: 24120911
[TBL] [Abstract][Full Text] [Related]
13. CsHscB Derived from a Liver Fluke Clonorchis Sinensis Ameliorates Cholestatic Hepatic Fibrosis in a Mouse Model of Sclerosing Cholangitis.
Yu Q; Koda S; Xu N; Li J; Wang JL; Liu M; Liu JX; Zhang Y; Yang HM; Zhang BB; Li XY; Li XC; Tang RX; Zheng KY; Yan C
Curr Mol Med; 2023 Apr; ():. PubMed ID: 37076961
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin binding to lipopolysaccharide lowers tumor necrosis factor-α and prevents early alcohol-induced liver injury in mice.
Ge X; Leung TM; Arriazu E; Lu Y; Urtasun R; Christensen B; Fiel MI; Mochida S; Sørensen ES; Nieto N
Hepatology; 2014 Apr; 59(4):1600-16. PubMed ID: 24214181
[TBL] [Abstract][Full Text] [Related]
15. Genetic or pharmacological reduction of cholangiocyte senescence improves inflammation and fibrosis in the
Alsuraih M; O'Hara SP; Woodrum JE; Pirius NE; LaRusso NF
JHEP Rep; 2021 Jun; 3(3):100250. PubMed ID: 33870156
[TBL] [Abstract][Full Text] [Related]
16. P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases.
Zhang J; Lyu Z; Li B; You Z; Cui N; Li Y; Li Y; Huang B; Chen R; Chen Y; Peng Y; Fang J; Wang Q; Miao Q; Tang R; Gershwin ME; Lian M; Xiao X; Ma X
Hepatology; 2023 Jul; 78(1):10-25. PubMed ID: 36799463
[TBL] [Abstract][Full Text] [Related]
17. Obeticholic acid aggravates liver injury by up-regulating the liver expression of osteopontin in obstructive cholestasis.
Wang J; Yuan Z; Zhang H; Wu Q; Miao Y; Xu Y; Yu Q; Huang X; Zhang Z; Huang X; Tang Q; Zhang L; Jiang Z
Life Sci; 2022 Oct; 307():120882. PubMed ID: 35963300
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 Ameliorates DDC-Induced Sclerosing Cholangitis and Biliary Fibrosis and Improves the Regenerative Capacity of the Liver.
Fragoulis A; Schenkel J; Herzog M; Schellenberg T; Jahr H; Pufe T; Trautwein C; Kensler TW; Streetz KL; Wruck CJ
Toxicol Sci; 2019 Jun; 169(2):485-498. PubMed ID: 30825315
[TBL] [Abstract][Full Text] [Related]
19. Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) mice.
Hsu W; Zhang W; Tsuneyama K; Moritoki Y; Ridgway WM; Ansari AA; Coppel RL; Lian ZX; Mackay I; Gershwin ME
Hepatology; 2009 Jan; 49(1):133-40. PubMed ID: 19065673
[TBL] [Abstract][Full Text] [Related]
20. [Establishment of a complex alcoholic liver fibrosis mouse model and investigation of OPN and TGF-beta1 hepatic expression].
Kong LB; Ren WG; Mi HM; Zhao SX; Zhang YG; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):207-12. PubMed ID: 23967743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
